Point-of-care technologies for molecular diagnostics using a drop of blood

Trends in Biotechnology

Volumn 32, Issue 3, 2014, Pages 132-139

  Song, Yujun ^a,b   Huang, Yu Yen ^c   Liu, Xuewu ^a,b   Zhang, Xiaojing ^c   Ferrari, Mauro ^a,b   Qin, Lidong ^a,b  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c The University of Texas at Austin   (United States)

Author keywords

Biomolecules; Circulating tumor cells; Molecular diagnostics; Nucleic acids; Point of care diagnostics; Proteins

Indexed keywords

BIOMOLECULES; CIRCULATING TUMOR CELLS; MOLECULAR DIAGNOSTICS; NUCLEIC ACIDS; POINT-OF-CARE DIAGNOSTICS; PROTEINS;

BIOLOGICAL MARKERS; BLOOD CHEMICAL ANALYSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; POINT-OF-CARE SYSTEMS;

EID: 84894253862     PISSN: 01677799     EISSN: 18793096     Source Type: Journal    
DOI: 10.1016/j.tibtech.2014.01.003     Document Type: Review

References (77)

1. Gutierrez G., et al. Clinical review: hemorrhagic shock. Crit. Care 2004, 8:373-381.
2. Marieb E.N. Essentials of Human Anatomy and Physiology 2008, Benjamin Cummings. 9th ed.
3. Huang S.J., et al. Clinical experience of hydroxyethyl starch (10% HES 200/0.5) in cerebral perfusion pressure protocol for severe head injury. Surg. Neurol. 2006, 66(Suppl. 2):S26-S31.
4. Medoff B.D., et al. Pathogenic T-cell recruitment into the airway in human disease. Ann. N. Y. Acad. Sci. 2005, 1062:220-241.
5. Calder P.C., et al. Early nutrition and immunity - progress and perspectives. Br. J. Nutr. 2006, 96:774-790.
6. Maton A.J.H., et al. Human Biology and Health 1993, Prentice Hall.
7. Loonen A.J., et al. Highlights from the 7th European meeting on molecular diagnostics. Expert Rev. Mol. Diagn. 2012, 12:17-19.
8. Gubala V., et al. Point of care diagnostics: status and future. Anal. Chem. 2011, 84:487-515.
9. Yager P., et al. Point-of-care diagnostics for global health. Annu. Rev. Biomed. Eng. 2008, 10:107-144.
10. Holland C.A., Kiechle F.L. Point-of-care molecular diagnostic systems - past, present and future. Curr. Opin. Microbiol. 2005, 8:504-509.
11. Cheng M.M., et al. Nanotechnologies for biomolecular detection and medical diagnostics. Curr. Opin. Chem. Biol. 2006, 10:11-19.
12. Gervais L., et al. Microfluidic chips for point-of-care immunodiagnostics. Adv. Mater. 2011, 23:H151-H176.
13. Myers F.B., Lee L.P. Innovations in optical microfluidic technologies for point-of-care diagnostics. Lab Chip 2008, 8:2015-2031.
14. Advances in Food Biochemistry 2010, CRC Press. F. Yildiz (Ed.).
15. Antman E.M., et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N. Engl. J. Med. 1996, 335:1342-1349.
16. Adkins J.N., et al. Toward a human blood serum proteome - analysis by multidimensional separation coupled with mass spectrometry. Mol. Cell. Proteomics 2002, 1:947-955.
17. Pieper R., et al. The human serum proteome: display of nearly 3700 chromatographically separated protein spots on two-dimensional electrophoresis gels and identification of 325 distinct proteins. Proteomics 2003, 3:1345-1364.
18. Warsinke A. Point-of-care testing of proteins. Anal. Bioanal. Chem. 2009, 393:1393-1405.
19. Chin C.D., et al. Microfluidics-based diagnostics of infectious diseases in the developing world. Nat. Med. 2011, 17:1015-1138.
20. Rissin D.M., et al. Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations. Nat. Biotechnol. 2010, 28:595-599.
21. de la Rica R., Stevens M.M. Plasmonic ELISA for the ultrasensitive detection of disease biomarkers with the naked eye. Nat. Nanotechnol. 2012, 7:821-824.
22. Stern E., et al. Label-free biomarker detection from whole blood. Nat. Nanotechnol. 2010, 5:138-142.
23. Gaster R.S., et al. Matrix-insensitive protein assays push the limits of biosensors in medicine. Nat. Med. 2009, 15:1327-1332.
24. Fan R., et al. Integrated barcode chips for rapid, multiplexed analysis of proteins in microliter quantities of blood. Nat. Biotechnol. 2008, 26:1373-1378.
25. Qin L.D., et al. Self-powered microfluidic chips for multiplexed protein assays from whole blood. Lab Chip 2009, 9:2016-2020.
26. Pollock N.R., et al. A paper-based multiplexed transaminase test for low-cost, point-of-care liver function testing. Sci. Transl. Med. 2012, 4:152ra129.
27. Vella S.J., et al. Measuring markers of liver function using a micropatterned paper device designed for blood from a fingerstick. Anal. Chem. 2012, 84:2883-2891.
28. Cheng C.M., et al. Paper-based ELISA. Angew. Chem. Int. Ed. Engl. 2010, 49:4771-4774.
29. Song Y.J., et al. Multiplexed volumetric bar-chart chip for point-of-care diagnostics. Nat. Commun. 2012, 3. 10.1038/ncomms2292.
30. Song Y., et al. A multistage volumetric bar chart chip for visualized quantification of DNA. J. Am. Chem. Soc. 2013, 35:16785-16788.
31. De M., et al. Sensing of proteins in human serum using conjugates of nanoparticles and green fluorescent protein. Nat. Chem. 2009, 1:461-465.
32. Hu Y., et al. Tailoring of the nanotexture of mesoporous silica films and their functionalized derivatives for selectively harvesting low molecular weight protein. ACS Nano 2010, 4:439-451.
33. Rosi N.L., Mirkin C.A. Nanostructures in biodiagnostics. Chem. Rev. 2005, 105:1547-1562.
34. Liu X., et al. A one-step homogeneous immunoassay for cancer biomarker detection using gold nanoparticle probes coupled with dynamic light scattering. J. Am. Chem. Soc. 2008, 130:2780-2782.
35. Jans H., Huo Q. Gold nanoparticle-enabled biological and chemical detection and analysis. Chem. Soc. Rev. 2011, 41:2849-2866.
36. Lander E.S., et al. Initial sequencing and analysis of the human genome. Nature 2001, 409:860-921.
37. Niemz A., et al. Point-of-care nucleic acid testing for infectious diseases. Trends Biotechnol. 2011, 29:240-250.
38. Lam B., et al. Solution-based circuits enable rapid and multiplexed pathogen detection. Nat. Commun. 2013, 4. 10.1038/ncomms3001.
39. Liong M., et al. Magnetic barcode assay for genetic detection of pathogens. Nat. Commun. 2013, 4:1752.
40. Gahan P.B., Swaminathan R. Circulating nucleic acids in plasma and serum - recent developments. Ann. N. Y. Acad. Sci. 2008, 1137:1-6.
41. Anker P., et al. Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients. Cancer Metastasis Rev. 1999, 18:65-73.
42. Stroun M., et al. About the possible origin and mechanism of circulating DNA - apoptosis and active DNA release. Clin. Chim. Acta 2001, 313:139-142.
43. Root B.E., et al. Purification of HIV RNA from serum using a polymer capture matrix in a microfluidic device. Anal. Chem. 2011, 83:982-988.
44. Liu K.J., et al. Decoding circulating nucleic acids in human serum using microfluidic single molecule spectroscopy. J. Am. Chem. Soc. 2010, 132:5793-5798.
45. Forshew T., et al. Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA. Sci. Transl. Med. 2012, 4:136ra68.
46. Yang Q., et al. Detection and differential diagnosis of colon cancer by a cumulative analysis of promoter methylation. Nat. Commun. 2012, 3. 10.1038/ncomms2209.
47. Chen X., et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008, 18:997-1006.
48. Labib M., et al. Three-mode electrochemical sensing of ultralow microRNA levels. J. Am. Chem. Soc. 2013, 135:3027-3038.
49. Dong H., et al. MicroRNA: function, detection, and bioanalysis. Chem. Rev. 2013, 113:6207-6233.
50. Wen Y., et al. DNA Nanostructure-based Interfacial engineering for PCR-free ultrasensitive electrochemical analysis of microRNA. Sci. Rep. 2012, 2:867.
51. Wang Y., et al. Nanopore-based detection of circulating microRNAs in lung cancer patients. Nat. Nanotechnol. 2011, 6:668-674.
52. Song Y., et al. Graphene oxide: intrinsic peroxidase catalytic activity and its application to glucose detection. Adv. Mater. 2010, 22:2206-2210.
53. Song Y., et al. Label-free colorimetric detection of single nucleotide polymorphism by using single-walled carbon nanotube intrinsic peroxidase-like activity. Chem. Eur. J. 2010, 16:3617-3621.
54. Song Y., et al. Light regulation of peroxidase activity by spiropyran functionalized carbon nanotubes used for label-free colorimetric detection of lysozyme. Chem. Commun. 2011, 47:9083-9085.
55. Song Y., et al. Visual and quantitative detection of copper ions using magnetic silica nanoparticles clicked on multiwalled carbon nanotubes. Chem. Commun. 2010, 46:6572-6574.
56. Xiang Y., Lu Y. Using personal glucose meters and functional DNA sensors to quantify a variety of analytical targets. Nat. Chem. 2011, 3:697-703.
57. Mousa N.A., et al. Droplet-scale estrogen assays in breast tissue, blood, and serum. Sci. Transl. Med. 2009, 1:p1ra2.
58. Jebrail M.J., et al. A digital microfluidic method for dried blood spot analysis. Lab Chip 2012, 11:3218-3224.
59. Shih S.C., et al. Dried blood spot analysis by digital microfluidics coupled to nanoelectrospray ionization mass spectrometry. Anal. Chem. 2012, 84:3731-3738.
60. Hunter R.A., et al. Microfluidic amperometric sensor for analysis of nitric oxide in whole blood. Anal. Chem. 2013, 85:6066-6072.
61. Miller M.C., et al. Significance of circulating tumor cells detected by the CellSearch System in patients with metastatic breast colorectal and prostate cancer. J. Oncol. 2012, 2010:617421.
62. Huang Y.Y., et al. Immunomagnetic nanoscreening of circulating tumor cells with a motion controlled microfluidic system. Biomed. Microdevices 2013, 15:673-681.
63. Hoshino K., et al. Computational analysis of microfluidic immunomagnetic rare cell separation from a particulate blood flow. Anal. Chem. 2012, 84:4292-4299.
64. Hoshino K., et al. Microchip-based immunomagnetic detection of circulating tumor cells. Lab Chip 2011, 11:3449-3457.
65. Ozkumur E., et al. Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells. Sci. Transl. Med. 2013, 5:179ra147.
66. Chen P., et al. Multiscale immunomagnetic enrichment of circulating tumor cells: from tubes to microchips. Lab Chip 2014, 14:446-458.
67. Myung J.H., et al. Dendrimer-mediated multivalent binding for the enhanced capture of tumor cells. Angew. Chem. Int. Ed. Engl. 2011, 50:11769-11772.
68. Zhao L., et al. High-purity prostate circulating tumor cell isolation by a polymer nanofiber-embedded microchip for whole exome sequencing. Adv. Mater. 2013, 25:2897-2902.
69. Yoon H.J., et al. Sensitive capture of circulating tumour cells by functionalized graphene oxide nanosheets. Nat. Nanotechnol. 2013, 8:735-741.
70. Wang S., et al. Three-dimensional nanostructured substrates toward efficient capture of circulating tumor cells. Angew. Chem. Int. Ed. Engl. 2009, 48:8970-8973.
71. Zhang W., et al. Microfluidics separation reveals the stem-cell-like deformability of tumor-initiating cells. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:18707-18712.
72. Zheng S., et al. 3D microfilter device for viable circulating tumor cell (CTC) enrichment from blood. Biomed. Microdevices 2011, 13:203-213.
73. Gascoyne P.R., et al. Isolation of rare cells from cell mixtures by dielectrophoresis. Electrophoresis 2009, 30:1388-1398.
74. Stott S.L., et al. Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:18392-18397.
75. Hindson B.J., et al. High-throughput droplet digital PCR system for absolute quantitation of DNA copy number. Anal. Chem. 2011, 83:8604-8610.
76. Lim L.S., et al. Microsieve lab-chip device for rapid enumeration and fluorescence in situ hybridization of circulating tumor cells. Lab Chip 2012, 12:4388-4396.
77. Punnoose E.A., et al. Molecular biomarker analyses using circulating tumor cells. PLoS ONE 2010, 5:e12517.